BCM
CYT
BML Capital Management’s Cyteir Therapeutics, Inc. Common Stock CYT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-3,654,053
| Closed | -$11M | – | 35 |
|
|
2024
Q1 | $11M | Buy |
3,654,053
+404,045
| +12% | +$1.22M | 7.25% | 6 |
|
|
2023
Q4 | $9.88M | Hold |
3,250,008
| – | – | 7.48% | 4 |
|
|
2023
Q3 | $9.23M | Buy |
3,250,008
+8
| +0% | +$23 | 8.48% | 4 |
|
|
2023
Q2 | $8.45M | Buy |
3,250,000
+103,704
| +3% | +$270K | 7.6% | 3 |
|
|
2023
Q1 | $5.73M | Buy |
+3,146,296
| New | +$5.73M | 4.95% | 5 |
|